WO1988010108A1 - Device for monitoring breathing during sleep and control of cpap treatment - Google Patents

Device for monitoring breathing during sleep and control of cpap treatment Download PDF

Info

Publication number
WO1988010108A1
WO1988010108A1 PCT/AU1988/000215 AU8800215W WO8810108A1 WO 1988010108 A1 WO1988010108 A1 WO 1988010108A1 AU 8800215 W AU8800215 W AU 8800215W WO 8810108 A1 WO8810108 A1 WO 8810108A1
Authority
WO
WIPO (PCT)
Prior art keywords
patient
cpap
snoring
pressure
air
Prior art date
Application number
PCT/AU1988/000215
Other languages
French (fr)
Inventor
Colin Edward Sullivan
Christopher Lynch
Original Assignee
Travenol Centre For Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Travenol Centre For Medical Research filed Critical Travenol Centre For Medical Research
Publication of WO1988010108A1 publication Critical patent/WO1988010108A1/en
Priority to US07/806,157 priority Critical patent/US5199424A/en
Priority to US07/892,692 priority patent/US5245995A/en
Priority to US08/371,083 priority patent/US5522382A/en
Priority to US08/934,176 priority patent/US6635021B1/en
Priority to US09/365,643 priority patent/US6398739B1/en
Priority to US09/875,326 priority patent/US6705315B2/en
Priority to US10/050,163 priority patent/US7004908B2/en
Priority to US10/086,444 priority patent/US6770037B2/en
Priority to US11/186,695 priority patent/US7141021B2/en
Priority to US11/554,378 priority patent/US20070051371A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/56Devices for preventing snoring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0051Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes with alarm devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0057Pumps therefor
    • A61M16/0066Blowers or centrifugal pumps
    • A61M16/0069Blowers or centrifugal pumps the speed thereof being controlled by respiratory parameters, e.g. by inhalation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/021Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes operated by electrical means
    • A61M16/022Control means therefor
    • A61M16/024Control means therefor including calculation means, e.g. using a processor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0015Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
    • A61M2016/0018Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
    • A61M2016/0024Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical with an on-off output signal, e.g. from a switch

Definitions

  • the present invention relates to the diagnosis and treatment of partial or complete upper airway occlusion, a condition where the upper airway collapses, particularly under the reduced pressure generated by inhalation. This is most likely to happen during unconsciousness, sleep or anaesthesia.
  • a particular application of the present invention is to the diagnosis and/or treatment of snoring and sleep apnea.
  • Sleep apnea is characterised by complete occlusion of the upper airway passage during sleep while snoring is characterised by partial occlusion.
  • Obstructive sleep apnea sufferers repeatedly choke on their tongue and soft palate throughout an entire sleep period resulting in lowered arterial blood oxygen levels and poor quality of sleep. It should be realised that although the following specification discusses sleep apnea in detail, the present invention also applies to the diagnosis and treatment of other forms of upper airway disorders. • t Reference to international patent publication
  • WO 82/03548 will show that the application of continuous positive airway pressure (CPAP) has been used as a means of treating the occurrence of obstructive sleep apnea.
  • CPAP continuous positive airway pressure
  • the patient is connected to a positive pressure air supply by means of a nose mask or nasal prongs.
  • the air supply breathed by the patient is at all times, at slightly greater than atmospheric pressure.
  • gauge pressures will typically be within the range of 2cm - 25cm. It has been found that the application of continuous positive airway pressure provides what can be described as a "pneumatic splint", supporting and stabilizing the upper airway and thus eliminating the occurrence of upper airway occlusions. It is effective in eliminating both snoring and obstructive sleep apnea and in many cases, is effective in treating central and mixed apnea.
  • the airway pressure required for effective CPAP therapy differs from patient to patient.
  • the practice has been for the patient to undergo two sleep studies at an appropriate observation facility such as a hospital, clinic or laboratory.
  • the first night is spent observing the patient in sleep and recording selected parameters such as arterial oxygen saturation, chest wall and abdominal movement, air flow, expired CO 2 , ECG, EEG, EMG and eye movement.
  • This information can be interpreted to diagnose the nature of the sleeping disorder and confirm the presence or absence of apnea and where present, the frequency and duration of apneic episodes and extent and duration of associated oxygen desaturation.
  • Apneas can be identified as obstructive, central or mixed.
  • the second night is spent with the patient undergoing nasal CPAP therapy.
  • the CPAP setting is increased to prevent the apnea.
  • the pressure setting at the end of the sleep period i.e. the maximum used, is deemed to be the appropriate setting for that patient.
  • these various pressures will, in fact, vary from day to day depending upon the patient's physical condition, for example, nasal congestion, general tiredness, effects of drugs such as alcohol, as well as their sleeping posture.
  • the appropriate pressure found in the laboratory is necessarily the maximum of all these minimum pressures for that particular night and is not necessarily the ideal pressure for all occasions nor for every night. It will generally be higher than necessary for most of the night.
  • International Patent publication W0/86/05965 discloses an apparatus which includes acoustic respiration sensors, background sound sensors and movement sensors. Such apparatus are capable of detecting breathing sounds, comparing those sounds with body movements and background noises and by further comparing the results with a data base of information, to indicate whether the patient is undergoing a normal or abnormal breathing pattern. Such apparatus can sound an alarm on the occurrence of apnea.
  • diagnosis in a sleep clinic as outlined above is beneficial, it has some deficiencies.
  • a patient is likely not to sleep in a fully relaxed state in an unfamiliar environment and a single night is insufficient to obtain a pressure setting that will be optimal in the long run.
  • home therapy at the pressure setting arrived at in this way is likely to be less than 100% effective on some occasions and higher than necessary for a substantial portion of the time.
  • the cost and inconvenience of a sleep study in a hospital setting are to be avoided if possible.
  • a skilled physician can usually recognise the symptoms of sleep apnea from questioning and examining a patient. Where no other indications are present there is very little risk in attempting nasal CPAP therapy without further testing as the treatment is fail safe and non- invasive . However, a very useful intermediate step would be to analyse the pattern of respiratory sounds over one or more full nights of sleep. Interpretation of these patterns together with questioning and examination will, in many cases, provide sufficient confirmation of apnea to prescribe nasal CPAP therapy. If nasal CPAP eliminates the symptoms of day time sleepiness (as assessed by the patient) and of apneic snoring patterns (as assessed by analysis of recorded respiratory sounds while on nasal CPAP), the treatment can be continued.
  • the present inventors have recognized the detection of the noise of snoring or more particularly snoring patterns as a reliable parameter for detecting apneas as well as the imminent onset of apneic episodes.
  • Characteristic snoring patterns can be associated with various sleep conditions including apnea and in fact in most (perhaps 95%) of sleep apnea sufferers, distinctive snoring patterns closely precede apneic episodes as will be later discussed.
  • a pressure transducer such as a microphone is a suitable detector of these characteristic snoring sounds, and in particular the sounds of snoring patterns.
  • the quality of the sounds monitored can be enhanced by placing the microphone within an enclosure which is in sound communication with a patient's respiratory system.
  • a physical noise barrier isolates the microphone from external sounds. If the enclosure is in sound communication with the patient's respiratory system the natural stethoscope effect of the patient's respiratory system is thereby exploited.
  • a further benefit of such a device is that the microphone is not in direct contact with any part of the patient's body. Thus, relative movement between the microphone and the patient's body, which is a noise source as far as monitoring is concerned, can be avoided .
  • a snoring monitor can accordingly be used at least as a preliminary diagnostic tool with or without monitoring other physiological parameters to provide information on the frequency and severity of snoring, hypopnea and apnea in a patient. Its simplicity and inexpensive nature allows it to be used at home in the patient's usual environment without the expense of a night in a sleep clinic. In some cases, e.g., where unusual snoring patterns are encountered, the diagnosis of the data from the snoring monitor will not be conclusive and the traditional full diagnosis in a sleep clinic will be required .
  • a diagnostic device comprising a nose piece substantially fluidly sealable to, or in sealed fluid communication with, the nasal air passages of a patient, a sound transducer in sound communication with the interior of the nose piece so as to be in use in sound communication with the respiratory system of the patient and to detect, and produce a signal responsive to the sounds of patient snoring, and recording equipment associated with the sound transducer for recording information indicative of the signal .
  • the intensity of the signal is recorded with respect to time.
  • the microphone output is fed through an amplifier or filter to differentiate normal breathing sounds from those indicative of snoring, and the intensities and time pattern of the differentiated sounds are recorded.
  • the frequency and duration of airway occlusions are calculated by preprogrammed processing of the detected signal, the processed signal is recorded as a time chart or a table interpreted by the physician.
  • a snoring monitor provides an effective substitute for the traditional first night in the sleep clinic.
  • diagnosis indicates CPAP therapy to be appropriate
  • the patient can go straight to the traditional second night at the sleep clinic so as to determine their appropriate CPAP setting for their condition, or they could commence use of an automatic CPAP device such as the unit described hereunder.
  • the monitoring of snoring patterns is useful not only for recording information regarding those patterns for diagnostic purposes but is also useful in that certain snoring patterns are a precursor to most apneic episodes in a large proportion of sleep apnea victims.
  • an effective CPAP device can be controlled by a feedback system in which snoring patterns are monitored and CPAP pressure is raised at the detection of predefined snoring patterns so as to provide increased airway pressure before, and in fact generally prevent the occurrence of, apneic episodes.
  • a feedback control comprising a sound monitoring device in sound communication with the respiratory system of a patient when using the apparatus, and a processor responsive to output from the sound monitoring device so as to control CPAP pressure according to patient requirements as determined by output from the sound monitoring device in order to prevent apneic episodes.
  • the feedback control is co-operative with a variable speed air compressor of the CPAP apparatus, the processor regulating the speed of the compressor when in use by increasing speed in response to a said signal equivalent to a preprogrammed signal indicative of a predetermined snoring pattern.
  • the control system furthermore decreases speed of the air compressor in the absence of the signal after a period of time in accordance with the predefined procedure.
  • a CPAP apparatus including a variable speed air compressor, a nose piece for sealed air communication with a patient's respiratory system, an air line from the compressor to the nose piece, an enclosed microphone connected to the air line so as to be in sound communication with the patient's respiratory system, and a feedback system controlling the speed of the air compressor in response to an output from the microphone so as to increase compressor speed in response to detected sound indicative of heavy snoring in accordance with a predefined procedure.
  • the feedback system reduces the speed of the air compressor in response to an absence of the said sound in accordance with the predefined procedure.
  • a further aspect of the invention which provides a variable speed air compressor and control system in the CPAP apparatus, the control system regulating the speed of the compressor when in use by increasing its speed in accordance with a predefined procedure whereby the commencement of operation of the compressor occurs at a preselected minimum speed with a gradually increasing compressor speed over a preselected period of time to a preselected maximum speed.
  • This embodiment of the invention provides an advantage in that the patient is exposed to a comfortably low pressure before falling asleep and during initial stages of sleep while the necessary therapeutic pressure is reached by the time it is required.
  • Fig. la is a schematic sectional view of one embodiment of a snoring detection apparatus in accordance with the present invention.
  • Fig. lb is a schematic sectional view of another embodiment of a snoring detection apparatus in accordance with the present invention.
  • Fig. 2a is a slow recording of sound levels obtained using the monitor of the present invention for a patient suffering from sleep apnea;
  • Fig. 2b shows the correlation of sound patterns and blood oxygen levels during a period of repetitive obstructive apnea
  • Fig. 3 is a diagram of a further embodiment of the present invention.
  • Fig. 4 is a circuit diagram of the device of Fig. 3;
  • Fig. 5 is a diagram of an embodiment of another aspect of the invention.
  • Fig. 6 is a circuit diagram of the device of Fig. 5.
  • Fig. la illustrates a snoring detection device 10 comprising a microphone 11, in sound communication with the container 12 of a nose mask.
  • Air being inhaled by the patient, enters the nasal passageways 14 through the opening 13 in the nose mask 12 and is exhaled in the reverse direction.
  • the microphone 11 is ideally located to take advantage of the natural stethoscope formed by the enclosed airway. Hence the snoring and breathing sounds are focused and concentrated by this arrangement.
  • the microphone 11 may be located within, or attached externally of, a nasal prong device as illustrated in Fig. lb.
  • the detection device 10 can be used in a diagnostic device or a feedback control.
  • the detection device 10 being used in diagnostic equipment there is connected to the microphone 11 an electronic processor/recorder which records signals from the microphone 11 either on a time basis or after preprogrammed processing so as to record for example tables of indexes such as the number of apneic episodes, their duration, etc.
  • the recorded data can then be reviewed by the physician for diagnosis.
  • Fig. 2a shows a graph representing sound amplitudes recorded from the snoring detection device 10.
  • the major calibration in the time scale direction represents two minutes .
  • the effect of blower motor noise can be diminished or completely removed by setting a low gain on the recording device or passing the signal through an amplitude filter to effectively ignore all sounds below a particular minimum amplitude or by passing the signals through a low pass frequency filter to effectively ignore sounds above its cut-off frequency.
  • An alternative method is to use a sound attenuator in the air line proximate the blower.
  • Part A of Fig. 2a is indicative of normal breathing
  • part B indicates soft to moderate snoring
  • part C shows constant loud snoring
  • part E shows periods of silence punctuated by snoring.
  • section D of the chart of Fig. 2a it can be seen that the breathing sound intensity rises and falls. This is indicative of obstructive hypopnea, a condition in which the breath-by-breath intensity decreases progressively, and then increases.
  • the decreasing intensity of the snoring occurs when the upper airway is almost, but not entirely, _ sucked closed by strong inspiratory efforts. This pattern is a "pre-apneic". pattern.
  • the following part E is therefore quickly interpreted by a skilled physician as being indicative of sleep apnea, with periods of airway occlusion which terminate with one or more loud breathing sounds followed by further occlusions.
  • the correlation between snoring patterns and arterial oxygen is shown in Fig. 2b.
  • the snoring patterns are an accurate parameter for detecting imminent apneic episodes, and more importantly periods of low oxygen supply to the brain and other organs.
  • recorded information derived from the signal of the device 10 can be used for diagnostic purposes, such as initial diagnosis of sleep apnea, without the need for the patient to stay overnight at an observation facility.
  • the sound patterns can be analysed by a programmed microprocessor within the diagnostic unit so as to record tables of indexes such as number of apneic episodes, their duration and time of occurrence. This is of economic significance because the cost of one overnight observation is comparable to the purchase price of a CPAP device.
  • the nose prongs and mask 12 are convenient forms of containers for the monitor device 10 however the container could take any other convenient form.
  • diagnostic apparatus in accordance with the present invention is suited for use by a patient with minimal supervision and therefore may be used successfully at home, the recorded diagnostic information being conveniently presented for expert analysis.
  • the CPAP unit comprises a motor 20 which drives a blower 21.
  • the speed of the motor 20 is controlled by an electronic speed control unit 23.
  • the speed control unit can be manipulated to vary the output pressure of the blower 21.
  • the CPAP device also includes a snoring detection means 22 wherein sounds are detected by a microphone 11.
  • the snoring detection means 22 is conveniently in the form of the previously described device 10. Electrical impulses are fed from said microphone 11 to an amplifier/filter/ processor unit 26 which generates an electrical signal when snoring sounds occur.
  • the motor speed control means is electrically connected to the snoring detection device 22 and increases the speed of the electric motor 20 by an analogue means in response to the electrical signal generated by the snoring detection device. Accordingly, the output pressure of the CPAP unit increases in response to detection of snoring.
  • snoring detection means 22 When a snore or sequence of snores is detected by the snoring detection means 22 a signal is generated.
  • the speed control unit 23 increases the speed of the fan motor and the output pressure is increased.
  • Snoring is itself undesirable not only as it is a disturbance to others but it is strongly believed to be connected with hypertension. If the resultant increase in CPAP pressure is sufficient to completely stabilize the airway, snoring will cease.
  • the CPAP pressure is increased again. This process is repeated until the upper airway is stabilized and snoring ceases. Hence, the occurrence of obstructive apnea can be eliminated by application of a minimum appropriate pressure at the time of use.
  • the preferred embodiment also includes a means to decrease the pressure if an extended period of snore free breathing occurs. For example, this can be done by automatically reducing the CPAP pressure at a gradual rate as long as snoring is not detected.
  • the rate at which the CPAP pressure is decreased in the absence of snoring is preferably much less than the rate at which it is increased when snoring is detected.
  • a patient may connect himself to the CPAP unit and go to sleep.
  • the CPAP pressure is initially at a minimum operating value of, for example, approximately 3cm H 2 0 gauge pressure so as not to cause the previously mentioned operational problems of higher initial pressures. Not until some time after going to sleep, and the patient's body relaxes, will the airway start to become unstable and the patient start to snore.
  • the detection apparatus 22 will then respond to the snore, or snore pattern, and via the processor 26 increase the motor speed such that CPAP pressure increases by 1cm H 2 0 for each snore detected.
  • the CPAP pressure can be increased relatively rapidly, if the patient's condition so requires, to a working pressure of the order of 8-10cm, which is a typical requirement.
  • An upper pressure limiting device can be incorporated for safety.
  • a paramater such as pressure output can be recorded in some convenient retrievable form for periodic study by the physician.
  • the CPAP unit of the present invention will not increase the pressure until needed, that is, unless the airway becomes unstable and snoring recommences no increase is made to the airway pressure .
  • the pressure By continuously decreasing the CPAP pressure at a rate of, for example, 1cm H 2 0 each 15 mins. in the absence of snoring the pressure is never substantially greater than that required to prevent apnea. However, when a snore, or snoring patterns, is detected. The decreasing CPAP pressure mode will be completely overwhelmed by a greater increase, about 1 cm H 2 0 predetected snore or snoring pattern. Once a stable sleeping pattern is achieved, the preferred embodiment will then continually test to ensure that the CPAP pressure is as low as is practicable.
  • a patient normally makes at least one loud snort or snoring sound at the end of an occurrence of apnea and the present invention will respond to this unusually loud sound to increase the CPAP pressure.
  • the airway pressure can still be adjusted upward in response to the abnormally loud breathing sounds generated at the end of the apneic period.
  • the present invention thus provides a CPAP device which modifies the CPAP pressure according to variations in a patient's requirements throughout an entire sleep period. It will be clear to those skilled in the art that the present invention can cope with the variation in airway pressure requirements such as may occur during a single sleep period, it will also be able to cope with variations in CPAP pressure requirements due to a general improvement or deterioration in a patient's general condition as may take place over a longer period of time.
  • Fig. 5 illustrates in block form the circuitry of the CPAP device of Fig. 4.
  • a snoring detection apparatus 22 is comprised of the microphone 11 attached to the nose mask 12.
  • the electrical signals of the microphone 11 are sent to a Fil er/Amplifier/Processor 26 which generates a control signal indicative of the recognition of a snoring pattern equivalent to a predetermined pattern.
  • Such control signals are sent to a feedback speed controller 23.
  • the speed controller 23 comprises a ramps generator and voltage to frequency converter 24 for control of a switch mode power supply (SMPS) 15, which provides the power to run the motor 20 turning the blower 21.
  • SMPS switch mode power supply
  • the maximum output of the SMPS 15, and therefore the maximum pressure delivered to the mask 12, is limited by a pressure- time control 17.
  • a control circuit 33 comprising a delay control 25, a timer 24, a switch mode power supply (SMPS) 15, and an upper pressure control 17.
  • SMPS switch mode power supply
  • the timer 24 a square wave pulse train, is ' generated where the duty ratio can be varied by the delay control 25.
  • This pulse train in the form of a current, is applied to a capacitor 19 to obtain a ramp voltage.
  • the output of the timer 24 and the input of the SMPS 15 is a voltage increasing with respect to time.
  • the minimum blower speed is preset so as to give effective operation of the air blower 21 and a minimum airway pressure which is comfortable to the patient. Typically a minimum pressure of 3-5 cm H 2 0 will have negligible effect on most patients.
  • the desired maximum airway pressure is set by adjusting the variable control 17. The magnitude of this pressure will vary according to the requirements of the individual patient but will typically be in the range 10-20 cm H 2 0.
  • the apparatus commences operation at the minimum motor speed and gradually increases the motor speed over a period of time selected before reaching the maximum preselected speed according to the previous adjustment of control 17.
  • the delay control 25 is set to zero minutes airway pressure comes up to the full level as set by adjustment 17 in a short period of time.
  • sleep is commenced with a low and comfortable air pressure but then automatically increased after a selectable period of time to the desired therapeutic pressures so as to to provide an adequate pneumatic splint to the airway passages during the latter stages of sleep when apnea is likely.
  • a convenient way to gauge whether a correct therapeutic, or maximum, pressure has been selected is to use the diagnostic device 10 of this invention while the patient is undergoing CPAP therapy. Should the recorded data show no signs of apneic periods then the setting may be assumed to be adequate at least for the patient when in a similar physical condition.
  • Another long term benefit can be gained by recording the pressure level applied to the patient during sleep periods in which CPAP is applied using the feedback device of this invention. By making such recordings spaced over a period of time the skilled physician can diagnose any long term changes in the patient's condition.

Abstract

A CPAP apparatus including: a variable pressured air source including an air compressor and means to vary the air pressure delivered therefrom (23); a nose piece (22) for sealed air communication with a patient's respiratory system (12); an air communication line from the air source (21) to the nose piece (22); a sound transducer (11) adapted to be in sound communication with the patient's respiratory system (12); and a feedback system (26) controlling the output pressure of the air source (21) in response to an output from the transducer (11) so as to increase the output air pressure from said air source (21), in response to detection of sound indicative of snoring, in accordance with a predefined procedure.

Description

"DEVICE FOR MONITORING BREATHING DURING SLEEP
AND CONTROL OF CPAP TREATMENT"
BACKGROUND ART
The present invention relates to the diagnosis and treatment of partial or complete upper airway occlusion, a condition where the upper airway collapses, particularly under the reduced pressure generated by inhalation. This is most likely to happen during unconsciousness, sleep or anaesthesia. A particular application of the present invention is to the diagnosis and/or treatment of snoring and sleep apnea. Sleep apnea is characterised by complete occlusion of the upper airway passage during sleep while snoring is characterised by partial occlusion. Obstructive sleep apnea sufferers repeatedly choke on their tongue and soft palate throughout an entire sleep period resulting in lowered arterial blood oxygen levels and poor quality of sleep. It should be realised that although the following specification discusses sleep apnea in detail, the present invention also applies to the diagnosis and treatment of other forms of upper airway disorders. • t Reference to international patent publication
WO 82/03548 will show that the application of continuous positive airway pressure (CPAP) has been used as a means of treating the occurrence of obstructive sleep apnea.
The patient is connected to a positive pressure air supply by means of a nose mask or nasal prongs. The air supply breathed by the patient, is at all times, at slightly greater than atmospheric pressure. For example, gauge pressures will typically be within the range of 2cm - 25cm. It has been found that the application of continuous positive airway pressure provides what can be described as a "pneumatic splint", supporting and stabilizing the upper airway and thus eliminating the occurrence of upper airway occlusions. It is effective in eliminating both snoring and obstructive sleep apnea and in many cases, is effective in treating central and mixed apnea.
The airway pressure required for effective CPAP therapy differs from patient to patient. In order to discover the airway pressure which is most effective for a particular individual, the practice has been for the patient to undergo two sleep studies at an appropriate observation facility such as a hospital, clinic or laboratory. The first night is spent observing the patient in sleep and recording selected parameters such as arterial oxygen saturation, chest wall and abdominal movement, air flow, expired CO2 , ECG, EEG, EMG and eye movement. This information can be interpreted to diagnose the nature of the sleeping disorder and confirm the presence or absence of apnea and where present, the frequency and duration of apneic episodes and extent and duration of associated oxygen desaturation. Apneas can be identified as obstructive, central or mixed. The second night is spent with the patient undergoing nasal CPAP therapy. When apnea is observed the CPAP setting is increased to prevent the apnea. The pressure setting at the end of the sleep period, i.e. the maximum used, is deemed to be the appropriate setting for that patient. For a given patient in a given physical condition there will be found different minimum pressures for various stages of sleep in order to prevent occlusions. Furthermore, these various pressures will, in fact, vary from day to day depending upon the patient's physical condition, for example, nasal congestion, general tiredness, effects of drugs such as alcohol, as well as their sleeping posture. Thus the appropriate pressure found in the laboratory is necessarily the maximum of all these minimum pressures for that particular night and is not necessarily the ideal pressure for all occasions nor for every night. It will generally be higher than necessary for most of the night.
Also patients must be able to operate a CPAP system to deliver appropriate airway pressure at their home where their general physical condition or state of health may be quite different to that in the sleep clinic, and will certainly vary from day to day. The patient's physical condition often improves due to CPAP therapy. It is often the case that after a period of therapy the necessary airway pressure can be reduced by some amount while still preventing the occurrence of obstructive sleep apnea. However, the prior- rt provides no facility to take advantage of this fact other than by regular diagnostic sleep periods in a sleep clinic or hospital. The long term effects of CPAP therapy are unknown so it is desirable to' keep the airway pressure as low as practicable, particularly if a patient requires long term treatment. Lower airway pressures also result in a lower face mask pressure which is generally more comfortable for the patient. It has been found that CPAP induces patients to swallow and this inducement to swallow can be reduced by lowering the airway pressure. Thus it is desirable to use the lowest practicable airway pressure that is effective in preventing airway occlusion during CPAP therapy for the comfort and, possibly, the long term safety of the patient. Also, a lower airway pressure requires less energy consumption and a less complex and therefore less expensive apparatus which is generally quieter. Low airway pressures are also desirable before and during the early stage of each sleep period as the increased comfort of an initially lower airway pressure allows the patient to more easily fall asleep. When a patient undergoing CPAP opens his mouth with pressurized air being forced through the nose the pressured air exits out of the mouth producing an unpleasant sensation. This can occur when the patient puts on the mask connected to the pressured air supply before falling asleep and some patients will therefore leave the mask off for as long as possible and may in fact fall asleep without wearing the mask and therefore without the benefits of the CPAP therapy.
Presently available CPAP units do not address this problem and so there is a need to provide a CPAP device which will be more acceptable to the patient before and during initial sleep by operating at an initially low pressure but automatically increasing to an appropriate therapeutic pressure before apnea occurs.
In addition to the problems associated with administering CPAP therapy there exists the inconvenience and cost of diagnosis which is currently undertaken "by overnight observation at a sleep clinic or the like. Hence a simple means whereby a patient's apnea problem can be diagnosed at home without supervision is clearly desirable as well as a CPAP device which will deliver a continuously minimum appropriate pressure for substantially the entire period of therapy.
Devices are available to detect apnea. For example, International Patent publication W0/86/05965 discloses an apparatus which includes acoustic respiration sensors, background sound sensors and movement sensors. Such apparatus are capable of detecting breathing sounds, comparing those sounds with body movements and background noises and by further comparing the results with a data base of information, to indicate whether the patient is undergoing a normal or abnormal breathing pattern. Such apparatus can sound an alarm on the occurrence of apnea.
Another device which could be readily adapted to detect and record the occurrence of apneic episodes is disclosed in US Patent No. 4,537,190. That apparatus is responsive to the CO2 levels in exhaled air during respiration and is also responsive to the absence of respiration (i.e. apnea) in which case it can switch on a ventilator. These devices are deficient in that they do not take advantage of the indication of apnea obtained exclusively from a recording from a single sound transducer (microphone) preferably located in the CPAP nose mask or prongs that can be interpreted by a skilled physician. The inherent simplicity of this form of measurement makes it safe and practicable for anybody to use in their own home with a minimum of prior instruction.
Although diagnosis in a sleep clinic as outlined above is beneficial, it has some deficiencies. A patient is likely not to sleep in a fully relaxed state in an unfamiliar environment and a single night is insufficient to obtain a pressure setting that will be optimal in the long run. Thus home therapy at the pressure setting arrived at in this way is likely to be less than 100% effective on some occasions and higher than necessary for a substantial portion of the time. The cost and inconvenience of a sleep study in a hospital setting are to be avoided if possible.
A skilled physician can usually recognise the symptoms of sleep apnea from questioning and examining a patient. Where no other indications are present there is very little risk in attempting nasal CPAP therapy without further testing as the treatment is fail safe and non- invasive . However, a very useful intermediate step would be to analyse the pattern of respiratory sounds over one or more full nights of sleep. Interpretation of these patterns together with questioning and examination will, in many cases, provide sufficient confirmation of apnea to prescribe nasal CPAP therapy. If nasal CPAP eliminates the symptoms of day time sleepiness (as assessed by the patient) and of apneic snoring patterns (as assessed by analysis of recorded respiratory sounds while on nasal CPAP), the treatment can be continued. Further check-ups can be conducted at intervals recommended by the physician. The measurement of other parameters would provide further information to assist diagnosis and the acoustic recording described above can readily be used in conjunction with other monitors such as ECG and/or pulse oximetry. Suitable monitors are available to measure both these parameters in the home but with increased information comes much higher cost of equipment and increase complexity in using the equipment. The correlation between reduced oxygen saturation and apnea is sufficiently well established to infer oxygen desaturation from the confirmation of an apneic event.
Diagnosis which are not conclusive from examination and home monitoring will continue to be confirmed from full sleep studies in a Sleep Disorders Centre.
Thus the prior art monitors and methods are deficient at least in that the resulting therapy is not 100% effective at all times, it is delivered at higher pressure than necessary for substantial periods, the equipment is expensive and has required diagnosis in specialised clinics . DISCL0SURE_0F_INVENTI0N
The present inventors have recognized the detection of the noise of snoring or more particularly snoring patterns as a reliable parameter for detecting apneas as well as the imminent onset of apneic episodes. Characteristic snoring patterns can be associated with various sleep conditions including apnea and in fact in most (perhaps 95%) of sleep apnea sufferers, distinctive snoring patterns closely precede apneic episodes as will be later discussed. A pressure transducer such as a microphone is a suitable detector of these characteristic snoring sounds, and in particular the sounds of snoring patterns. Furthermore, the quality of the sounds monitored can be enhanced by placing the microphone within an enclosure which is in sound communication with a patient's respiratory system. By enclosing the microphone, a physical noise barrier isolates the microphone from external sounds. If the enclosure is in sound communication with the patient's respiratory system the natural stethoscope effect of the patient's respiratory system is thereby exploited. A further benefit of such a device is that the microphone is not in direct contact with any part of the patient's body. Thus, relative movement between the microphone and the patient's body, which is a noise source as far as monitoring is concerned, can be avoided .
Monitoring of a patient's snoring patterns alone can in many instances provide information indicative of his/her condition, whether he/she suffers mild, medium or extreme apneic episodes, how often the episodes occur and therefore whether CPAP therapy will be beneficial. A snoring monitor can accordingly be used at least as a preliminary diagnostic tool with or without monitoring other physiological parameters to provide information on the frequency and severity of snoring, hypopnea and apnea in a patient. Its simplicity and inexpensive nature allows it to be used at home in the patient's usual environment without the expense of a night in a sleep clinic. In some cases, e.g., where unusual snoring patterns are encountered, the diagnosis of the data from the snoring monitor will not be conclusive and the traditional full diagnosis in a sleep clinic will be required .
Thus, in one form of this invention there is provided a diagnostic device comprising a nose piece substantially fluidly sealable to, or in sealed fluid communication with, the nasal air passages of a patient, a sound transducer in sound communication with the interior of the nose piece so as to be in use in sound communication with the respiratory system of the patient and to detect, and produce a signal responsive to the sounds of patient snoring, and recording equipment associated with the sound transducer for recording information indicative of the signal . In one preferred embodiment of the diagnostic device, the intensity of the signal is recorded with respect to time. In another embodiment of the diagnostic device the microphone output is fed through an amplifier or filter to differentiate normal breathing sounds from those indicative of snoring, and the intensities and time pattern of the differentiated sounds are recorded. In a further embodiment of the diagnostic device the frequency and duration of airway occlusions are calculated by preprogrammed processing of the detected signal, the processed signal is recorded as a time chart or a table interpreted by the physician.
Thus in a number of cases such a snoring monitor provides an effective substitute for the traditional first night in the sleep clinic. Where diagnosis indicates CPAP therapy to be appropriate the patient can go straight to the traditional second night at the sleep clinic so as to determine their appropriate CPAP setting for their condition, or they could commence use of an automatic CPAP device such as the unit described hereunder. The monitoring of snoring patterns is useful not only for recording information regarding those patterns for diagnostic purposes but is also useful in that certain snoring patterns are a precursor to most apneic episodes in a large proportion of sleep apnea victims. Thus, an effective CPAP device can be controlled by a feedback system in which snoring patterns are monitored and CPAP pressure is raised at the detection of predefined snoring patterns so as to provide increased airway pressure before, and in fact generally prevent the occurrence of, apneic episodes.
Thus, in another form of the invention there is provided in a CPAP apparatus a feedback control comprising a sound monitoring device in sound communication with the respiratory system of a patient when using the apparatus, and a processor responsive to output from the sound monitoring device so as to control CPAP pressure according to patient requirements as determined by output from the sound monitoring device in order to prevent apneic episodes. Preferably, the feedback control is co-operative with a variable speed air compressor of the CPAP apparatus, the processor regulating the speed of the compressor when in use by increasing speed in response to a said signal equivalent to a preprogrammed signal indicative of a predetermined snoring pattern.
Preferably, the control system furthermore decreases speed of the air compressor in the absence of the signal after a period of time in accordance with the predefined procedure. In another form of the feedback device of the invention there is provided a CPAP apparatus including a variable speed air compressor, a nose piece for sealed air communication with a patient's respiratory system, an air line from the compressor to the nose piece, an enclosed microphone connected to the air line so as to be in sound communication with the patient's respiratory system, and a feedback system controlling the speed of the air compressor in response to an output from the microphone so as to increase compressor speed in response to detected sound indicative of heavy snoring in accordance with a predefined procedure. Preferably the feedback system reduces the speed of the air compressor in response to an absence of the said sound in accordance with the predefined procedure. Disadvantages in the prior art are also ameliorated by a further aspect of the invention which provides a variable speed air compressor and control system in the CPAP apparatus, the control system regulating the speed of the compressor when in use by increasing its speed in accordance with a predefined procedure whereby the commencement of operation of the compressor occurs at a preselected minimum speed with a gradually increasing compressor speed over a preselected period of time to a preselected maximum speed. This embodiment of the invention provides an advantage in that the patient is exposed to a comfortably low pressure before falling asleep and during initial stages of sleep while the necessary therapeutic pressure is reached by the time it is required. H 5ISCRIPTI0N_0F_THE_DR WINGS
The present invention will now be described in detail by way of reference to the attached drawings in which:
Fig. la is a schematic sectional view of one embodiment of a snoring detection apparatus in accordance with the present invention;
Fig. lb is a schematic sectional view of another embodiment of a snoring detection apparatus in accordance with the present invention;
Fig. 2a is a slow recording of sound levels obtained using the monitor of the present invention for a patient suffering from sleep apnea;
Fig. 2b shows the correlation of sound patterns and blood oxygen levels during a period of repetitive obstructive apnea; Fig. 3 is a diagram of a further embodiment of the present invention;
Fig. 4 is a circuit diagram of the device of Fig. 3;
Fig. 5 is a diagram of an embodiment of another aspect of the invention; and Fig. 6 is a circuit diagram of the device of Fig. 5.
5I_iϊ__ϊ2_l_._2Z ≤_-_:_tI_:!!S_θ ϊ_ϊ5I_ϊNVENτιoN
Fig. la illustrates a snoring detection device 10 comprising a microphone 11, in sound communication with the container 12 of a nose mask. Air, being inhaled by the patient, enters the nasal passageways 14 through the opening 13 in the nose mask 12 and is exhaled in the reverse direction. As the airway extends from the source of snoring sounds within the patient's body, through the nasal passages 14 and out of the opening 13 in the nasal mask, the microphone 11 is ideally located to take advantage of the natural stethoscope formed by the enclosed airway. Hence the snoring and breathing sounds are focused and concentrated by this arrangement. Alternatively, the microphone 11 may be located within, or attached externally of, a nasal prong device as illustrated in Fig. lb. The detection device 10 can be used in a diagnostic device or a feedback control. In the case of the detection device 10 being used in diagnostic equipment there is connected to the microphone 11 an electronic processor/recorder which records signals from the microphone 11 either on a time basis or after preprogrammed processing so as to record for example tables of indexes such as the number of apneic episodes, their duration, etc. The recorded data can then be reviewed by the physician for diagnosis.
Fig. 2a shows a graph representing sound amplitudes recorded from the snoring detection device 10. The major calibration in the time scale direction represents two minutes . The effect of blower motor noise can be diminished or completely removed by setting a low gain on the recording device or passing the signal through an amplitude filter to effectively ignore all sounds below a particular minimum amplitude or by passing the signals through a low pass frequency filter to effectively ignore sounds above its cut-off frequency. An alternative method is to use a sound attenuator in the air line proximate the blower.
Part A of Fig. 2a is indicative of normal breathing, part B indicates soft to moderate snoring, part C shows constant loud snoring and part E shows periods of silence punctuated by snoring. In section D of the chart of Fig. 2a, it can be seen that the breathing sound intensity rises and falls. This is indicative of obstructive hypopnea, a condition in which the breath-by-breath intensity decreases progressively, and then increases. In this pattern the decreasing intensity of the snoring occurs when the upper airway is almost, but not entirely, _ sucked closed by strong inspiratory efforts. This pattern is a "pre-apneic". pattern. The following part E, is therefore quickly interpreted by a skilled physician as being indicative of sleep apnea, with periods of airway occlusion which terminate with one or more loud breathing sounds followed by further occlusions. The correlation between snoring patterns and arterial oxygen is shown in Fig. 2b. Clearly the snoring patterns are an accurate parameter for detecting imminent apneic episodes, and more importantly periods of low oxygen supply to the brain and other organs. Thus recorded information derived from the signal of the device 10 can be used for diagnostic purposes, such as initial diagnosis of sleep apnea, without the need for the patient to stay overnight at an observation facility. The sound patterns can be analysed by a programmed microprocessor within the diagnostic unit so as to record tables of indexes such as number of apneic episodes, their duration and time of occurrence. This is of economic significance because the cost of one overnight observation is comparable to the purchase price of a CPAP device. The nose prongs and mask 12 are convenient forms of containers for the monitor device 10 however the container could take any other convenient form.
Furthermore, diagnostic apparatus in accordance with the present invention is suited for use by a patient with minimal supervision and therefore may be used successfully at home, the recorded diagnostic information being conveniently presented for expert analysis.
In Fig. 3, a CPAP apparatus embodying the invention is illustrated. The CPAP unit comprises a motor 20 which drives a blower 21. The speed of the motor 20 is controlled by an electronic speed control unit 23. ■ As an increase in motor speed also increases the blower speed which in turn increases the output air pressure of the blower 21, the speed control unit can be manipulated to vary the output pressure of the blower 21. The CPAP device also includes a snoring detection means 22 wherein sounds are detected by a microphone 11. The snoring detection means 22 is conveniently in the form of the previously described device 10. Electrical impulses are fed from said microphone 11 to an amplifier/filter/ processor unit 26 which generates an electrical signal when snoring sounds occur. The motor speed control means is electrically connected to the snoring detection device 22 and increases the speed of the electric motor 20 by an analogue means in response to the electrical signal generated by the snoring detection device. Accordingly, the output pressure of the CPAP unit increases in response to detection of snoring.
When a snore or sequence of snores is detected by the snoring detection means 22 a signal is generated. The speed control unit 23 increases the speed of the fan motor and the output pressure is increased. As snoring is caused by vibration of the soft palate, it is therefore indicative of an unstable airway and, as previously described, is a warning signal of the imminence of upper airway occlusion in patients that suffer obstructive sleep apnea. Snoring is itself undesirable not only as it is a disturbance to others but it is strongly believed to be connected with hypertension. If the resultant increase in CPAP pressure is sufficient to completely stabilize the airway, snoring will cease. If a further snoring sound is detected, the CPAP pressure is increased again. This process is repeated until the upper airway is stabilized and snoring ceases. Hence, the occurrence of obstructive apnea can be eliminated by application of a minimum appropriate pressure at the time of use.
In order to ensure that the CPAP pressure is maintained at a level as low as practicable to prevent the onset of apnea, the preferred embodiment also includes a means to decrease the pressure if an extended period of snore free breathing occurs. For example, this can be done by automatically reducing the CPAP pressure at a gradual rate as long as snoring is not detected. The rate at which the CPAP pressure is decreased in the absence of snoring is preferably much less than the rate at which it is increased when snoring is detected. This can be achieved, for example, by the amplifier/filter/processor unit 26, in the absence of an electronic signal from the microphone 11, continuously gradually reducing the blower speed over a period of time but increasing the blower speed in incremental steps each time a snore is detected by the microphone 11.
In use, a patient may connect himself to the CPAP unit and go to sleep. The CPAP pressure is initially at a minimum operating value of, for example, approximately 3cm H20 gauge pressure so as not to cause the previously mentioned operational problems of higher initial pressures. Not until some time after going to sleep, and the patient's body relaxes, will the airway start to become unstable and the patient start to snore. The detection apparatus 22 will then respond to the snore, or snore pattern, and via the processor 26 increase the motor speed such that CPAP pressure increases by 1cm H20 for each snore detected. The CPAP pressure can be increased relatively rapidly, if the patient's condition so requires, to a working pressure of the order of 8-10cm, which is a typical requirement. An upper pressure limiting device can be incorporated for safety. Also, for ease of monitoring the variation over time in patient conditions, a paramater such as pressure output can be recorded in some convenient retrievable form for periodic study by the physician.
If for example in the early stages of sleep some lesser CPAP pressure will suffice, the CPAP unit of the present invention will not increase the pressure until needed, that is, unless the airway becomes unstable and snoring recommences no increase is made to the airway pressure .
By continuously decreasing the CPAP pressure at a rate of, for example, 1cm H20 each 15 mins. in the absence of snoring the pressure is never substantially greater than that required to prevent apnea. However, when a snore, or snoring patterns, is detected. The decreasing CPAP pressure mode will be completely overwhelmed by a greater increase, about 1 cm H20 predetected snore or snoring pattern. Once a stable sleeping pattern is achieved, the preferred embodiment will then continually test to ensure that the CPAP pressure is as low as is practicable. Should the CPAP pressure be decreased to such an extent that the upper airway becomes unstable and snoring recommences, the pressure is reincreased to ensure that apnea is prevented, it being remembered that the snoring pattern is a precursor to apneic episodes. The flexibility of the invention can be illustrated by the following example.
It is known that a patient's maximum propensity to suffer sleep apnea occurs during REM sleep. An airway that was otherwise stable at a given CPAP pressure may become unstable during REM sleep. Should this happen snoring will set in before apnea occurs. In such circumstances, the present invention will raise the CPAP pressure in response to the snoring, thus preventing the onset of apnea. After the REM sleep passes, the patient's airway becomes more stable and the higher airway pressure is no longer required. In such circumstances, the CPAP pressure will be gradually reduced until the first sign of snoring reoccurs at which point the pressure will again be increased. A patient normally makes at least one loud snort or snoring sound at the end of an occurrence of apnea and the present invention will respond to this unusually loud sound to increase the CPAP pressure. Thus even if apnea should occur without the usual precursor of snoring, the airway pressure can still be adjusted upward in response to the abnormally loud breathing sounds generated at the end of the apneic period.
The present invention thus provides a CPAP device which modifies the CPAP pressure according to variations in a patient's requirements throughout an entire sleep period. It will be clear to those skilled in the art that the present invention can cope with the variation in airway pressure requirements such as may occur during a single sleep period, it will also be able to cope with variations in CPAP pressure requirements due to a general improvement or deterioration in a patient's general condition as may take place over a longer period of time.
Fig. 5 illustrates in block form the circuitry of the CPAP device of Fig. 4. A snoring detection apparatus 22 is comprised of the microphone 11 attached to the nose mask 12. The electrical signals of the microphone 11 are sent to a Fil er/Amplifier/Processor 26 which generates a control signal indicative of the recognition of a snoring pattern equivalent to a predetermined pattern. Such control signals are sent to a feedback speed controller 23. The speed controller 23 comprises a ramps generator and voltage to frequency converter 24 for control of a switch mode power supply (SMPS) 15, which provides the power to run the motor 20 turning the blower 21.
The maximum output of the SMPS 15, and therefore the maximum pressure delivered to the mask 12, is limited by a pressure- time control 17.
In another aspect of the invention, shown in Figs. 5 and 6, there is provided a control circuit 33 comprising a delay control 25, a timer 24, a switch mode power supply (SMPS) 15, and an upper pressure control 17. In the timer 24 a square wave pulse train, is' generated where the duty ratio can be varied by the delay control 25. This pulse train, in the form of a current, is applied to a capacitor 19 to obtain a ramp voltage. Hence the output of the timer 24 and the input of the SMPS 15 is a voltage increasing with respect to time. The output of the SMPS 15, and therefore the motor voltage and speed, follow the input.
The minimum blower speed is preset so as to give effective operation of the air blower 21 and a minimum airway pressure which is comfortable to the patient. Typically a minimum pressure of 3-5 cm H20 will have negligible effect on most patients. The desired maximum airway pressure, being the intended therapeutic airway pressure, is set by adjusting the variable control 17. The magnitude of this pressure will vary according to the requirements of the individual patient but will typically be in the range 10-20 cm H20.
When the delay control 25 is not set to zero minutes, the apparatus commences operation at the minimum motor speed and gradually increases the motor speed over a period of time selected before reaching the maximum preselected speed according to the previous adjustment of control 17. When the delay control 25 is set to zero minutes airway pressure comes up to the full level as set by adjustment 17 in a short period of time.
By this arrangement sleep is commenced with a low and comfortable air pressure but then automatically increased after a selectable period of time to the desired therapeutic pressures so as to to provide an adequate pneumatic splint to the airway passages during the latter stages of sleep when apnea is likely. A convenient way to gauge whether a correct therapeutic, or maximum, pressure has been selected is to use the diagnostic device 10 of this invention while the patient is undergoing CPAP therapy. Should the recorded data show no signs of apneic periods then the setting may be assumed to be adequate at least for the patient when in a similar physical condition. Another long term benefit can be gained by recording the pressure level applied to the patient during sleep periods in which CPAP is applied using the feedback device of this invention. By making such recordings spaced over a period of time the skilled physician can diagnose any long term changes in the patient's condition.

Claims

CLAIMS: -
1. A CPAP apparatus including: a variable pressured air source including an air compressor and means to vary the air pressure delivered therefrom; a nose piece for sealed air communication with a patient's respiratory system; an air communication line from the air source to the nose piece; a sound transducer adapted to be in sound communication with the patient's respiratory system; and a feedback system controlling the output pressure of the air source in response to an output from the transducer so as to increase the output air pressure from said air source, in response to detection of sound indicative of snoring, in accordance with a predefined procedure.
2. Apparatus in claim 1 wherein the air source is a variable speed air compressor.
3. An apparatus as claimed in claim 2 wherein the feedback control system reduces the output pressure of the compressor in response to an absence of said sound in accordance with a further predefined procedure.
4. An apparatus as claimed in claim 3 wherein the transducer is a microphone rigid with the nose piece so as to receive vibrations caused by patient snoring.
5. An apparatus as claimed in claim 3 wherein the nose piece is a nose mask.
6. An apparatus as claimed in claim 3 wherein the transducer is a microphone enclosed within the nose piece being a nasal prong device.
7. An apparatus as claimed in claim 2 wherein the maximum speed of the air compressor selectable by the feedback control system is adjustably preselected.
8. A variable speed air compressor and control system for a CPAP apparatus, the control system regulating the speed of the compressor when in use by increasing speed in accordance with a predefined procedure.
9. An air compressor and control system as in claim 8 wherein the predefined procedure includes increasing the speed of the compressor in response to a predetermined signal indicative of patient snoring.
10. An air compressor and control system as claimed in claim 9 wherein the predefined procedure further includes decreasing the speed of the air compressor in the absence of the signal, the decrease in speed being at a preselected rate in accordance with a further predefined procedure.
11. A variable speed compressor and control system as claimed in claim 8 wherein the predefined procedure comprises commencing operation of the compressor at a preselected minimum speed and gradually increasing the speed over a preselected period of time to a preselected maximum speed.
12. A CPAP apparatus including a variable speed air compressor and control system as claimed in claim 10 wherein a compressed air outlet of the air compressor is connected to an air supply line of the CPAP apparatus, the supply line being furthermore connected to a nose piece for air communication to the respiratory system of the patient.
13. Diagnostic apparatus comprising a sound transducer adapted to be positioned in sound receiving communication with the respiratory system of a patient, recordal apparatus connected to the transducer for recording signals produced by the transducer responsive to sounds indicative of snoring patterns of the patient.
14. Apparatus as claimed in claim 13 wherein said signals comprise a processed output from the sound transducer recorded against time and indicating snoring patterns and/or snoring pattern indexes.
15. In a CPAP apparatus, a sound monitoring device in sound communication with the respiratory system of a patient when using the apparatus, and a control system responsive to output from the sound monitoring device so as to control CPAP pressure according to patient requirements as determined by output from the sound monitoring device. "
16. In a CPAP apparatus including a variable speed blower, a nose piece, and interconnecting air lines, a microphone fixed internally of the nose piece so as to be in sound communication with the respiratory system of a patient when using the apparatus, and a control system responsive to output from the microphone so as to control CPAP pressure according to patient requirements as determined by the output from the microphone.
17. A method of diagnosis including applying to a patient before sleep a nose piece containing a microphone connected to a microphone signal recording apparatus, and identifying snoring patterns where indicated by the recorded signal so as to diagnose occurrences of apneic episodes.
18. A method as defined in claim 17 wherein the microphone signals are processed by an electronic processor programmed so as to distinguish predefined snoring patterns and provide signals to the recording apparatus indicative of the occurrence of the predefined snoring pattern.
19. A method of CPAP therapy including monitoring a patient's snoring patterns using a sound transducer in sound communication with the patient's respiratory system, identifying predetermined characteristic snoring patterns by electronic analysis of signals from the transducer, and automatically increasing CPAP pressure delivered to the patient by a predetermined amount responsive to each identified said characteristic snoring pattern.
20. A method as defined in claim 19 wherein CPAP pressure delivered to the patient is automatically gradually decreased in the absence of said characteristic snoring patterns.
21. A method as defined in claim 19 wherein CPAP therapy is commenced at a low CPAP pressure delivered to the patient.
22. A method of CPAP therapy including commencing therapy at a preset minimum CPAP pressure delivered to the patient and then gradually increasing said pressure over a preset period of time to a preset therapeutic pressure.
23. A method of CPAP therapy as defined in claim 19 and "further recording pressure levels, against time, delivered to the patient.
24. A method of CPAP therapy as defined in claim 19 and further recording snoring pattern sounds against time so as to confirm correct operation of the CPAP apparatus.
PCT/AU1988/000215 1987-06-26 1988-06-27 Device for monitoring breathing during sleep and control of cpap treatment WO1988010108A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
US07/806,157 US5199424A (en) 1987-06-26 1991-12-12 Device for monitoring breathing during sleep and control of CPAP treatment that is patient controlled
US07/892,692 US5245995A (en) 1987-06-26 1992-05-27 Device and method for monitoring breathing during sleep, control of CPAP treatment, and preventing of apnea
US08/371,083 US5522382A (en) 1987-06-26 1995-01-10 Device and method for treating obstructed breathing having a delay/ramp feature
US08/934,176 US6635021B1 (en) 1987-06-26 1997-09-19 Method and apparatus useful in the diagnosis of obstructive sleep apnea of a patient
US09/365,643 US6398739B1 (en) 1987-06-26 1999-08-02 Device and method for nonclinical monitoring of breathing during sleep, control of CPAP treatment and preventing apnea
US09/875,326 US6705315B2 (en) 1987-06-26 2001-06-06 Device for monitoring breathing during sleep and ramped control of CPAP treatment
US10/050,163 US7004908B2 (en) 1987-06-26 2002-01-18 Method and apparatus useful in the diagnosis of obstructive sleep apnea of a patient
US10/086,444 US6770037B2 (en) 1987-06-26 2002-03-04 Method and apparatus useful in the diagnosis of obstructive sleep apnea of a patient
US11/186,695 US7141021B2 (en) 1987-06-26 2005-07-21 Method and apparatus useful in the diagnosis of obstructive sleep apnea of a patient
US11/554,378 US20070051371A1 (en) 1987-06-26 2006-10-30 Method and apparatus useful in the diagnosis of obstructive sleep apnea of a patient

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPI273087 1987-06-26
AUPI2730 1987-06-26
AUPI423487 1987-09-08
AUPI4234 1987-09-08

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US07457757 A-371-Of-International 1989-12-21
US54810890A Continuation-In-Part 1987-06-26 1990-07-05

Publications (1)

Publication Number Publication Date
WO1988010108A1 true WO1988010108A1 (en) 1988-12-29

Family

ID=25643312

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU1988/000215 WO1988010108A1 (en) 1987-06-26 1988-06-27 Device for monitoring breathing during sleep and control of cpap treatment

Country Status (1)

Country Link
WO (1) WO1988010108A1 (en)

Cited By (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0371424A1 (en) * 1988-11-30 1990-06-06 MADAUS SCHWARZER MEDIZINTECHNIK GmbH & Co. KG Monitoring device for the diagnosis of apnea
WO1990014121A1 (en) 1989-05-19 1990-11-29 Puritan-Bennett Corporation Inspiratory airway pressure system
WO1991000075A1 (en) * 1989-06-27 1991-01-10 Wennerholm Bjoern Device for temporary artificial respiration assistance for persons having snore problems
EP0419551A1 (en) * 1988-05-10 1991-04-03 Anatole J Sipin Gas delivery means.
EP0505232A1 (en) * 1991-03-21 1992-09-23 Taema Apparatus providing respiratory gas overpressure, and a control process therefor
WO1992022244A1 (en) * 1991-06-14 1992-12-23 Respironics, Inc. Method and apparatus for controlling sleep disorder breathing
EP0563044A1 (en) * 1990-12-21 1993-10-06 Puritan-Bennett Corporation Inspiratory airway pressure system
FR2692152A1 (en) * 1992-06-15 1993-12-17 Pierre Medical Sa Breathing aid apparatus, in particular for treating sleep apnea.
FR2698274A1 (en) * 1992-11-20 1994-05-27 Sefam Artificial respiration appts. with compression pump - includes pressure sensor and control unit for sensing and preventing any possible blockage of patient's airway
EP0612257A1 (en) * 1991-11-14 1994-08-31 University Technologies International Inc. Auto cpap system
EP0639088A1 (en) * 1992-05-07 1995-02-22 New York University Apnea treatment using adjustable positive airway pressure
EP0656216A2 (en) * 1993-12-03 1995-06-07 Resmed Limited Estimation of flow and detection of breathing in CPAP treatment
US5458137A (en) * 1991-06-14 1995-10-17 Respironics, Inc. Method and apparatus for controlling sleep disorder breathing
US5490502A (en) * 1992-05-07 1996-02-13 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
EP0699084A1 (en) * 1992-12-09 1996-03-06 Puritan Bennett Corporation Compliance meter for respiratory therapy
US5522382A (en) * 1987-06-26 1996-06-04 Rescare Limited Device and method for treating obstructed breathing having a delay/ramp feature
US5537997A (en) * 1995-01-26 1996-07-23 Respironics, Inc. Sleep apnea treatment apparatus and passive humidifier for use therewith
EP0722747A2 (en) * 1994-12-15 1996-07-24 Devilbiss Health Care, Inc. CPAP apparatus
US5540219A (en) * 1995-01-26 1996-07-30 Respironics, Inc. Sleep apnea treatment apparatus
US5549106A (en) * 1989-05-19 1996-08-27 Puritan-Bennett Corporation Inspiratory airway pressure system using constant pressure and measuring flow signals to determine airway patency
WO1997016216A1 (en) * 1995-10-31 1997-05-09 Compumedics Sleep Pty. Ltd. Apparatus for gas delivery
AU707148B2 (en) * 1995-10-31 1999-07-01 Compumedics Limited Apparatus for gas delivery
US5921238A (en) * 1994-09-12 1999-07-13 Nellcor Puritan Bennett France Developpement Pressure-controlled breathing aid
US5947115A (en) * 1995-01-26 1999-09-07 Respironics, Inc. Gas flow pressure filter
US6085747A (en) * 1991-06-14 2000-07-11 Respironics, Inc. Method and apparatus for controlling sleep disorder breathing
FR2800284A1 (en) * 1999-11-02 2001-05-04 Rene Filderman SUPPRESSION OF SOUND DISCOMFORT FROM CONTINUOUS PRESSURE DEVICES FOR THE TREATMENT OF SLEEP APNEA
DE10105383A1 (en) * 2001-02-06 2002-08-08 Heptec Gmbh Anti-snoring device, method for reducing snoring and air glasses
WO2004105846A2 (en) 2003-05-21 2004-12-09 Seleon Gmbh Control device for anti-snoring apparatus and an anti-snoring apparatus, for example for copd treatment
US7107992B2 (en) 2002-10-04 2006-09-19 Pavad Medical, Inc. System and method for preventing closure of passageways
WO2006133493A1 (en) 2005-06-14 2006-12-21 Resmed Limited Acclimatization therapy for first time cpap and niv users
EP1737520A1 (en) * 2004-04-15 2007-01-03 ResMed Limited Snoring treatment apparatus and methods of managing snorers
WO2007076582A1 (en) * 2006-01-06 2007-07-12 Resmed Ltd Computer controlled cpap system with snore detection
DE102004011078B4 (en) * 2004-03-06 2007-11-15 Golden, Eduard, Dr. Respiratory Equipment
WO2009103111A1 (en) * 2008-02-19 2009-08-27 Charles Rupert Russell-Smith Patient's breathing detection and monitoring
US7836888B2 (en) 2004-09-21 2010-11-23 Pavad Medical, Incorporated Airway implant and methods of making and using
US7882842B2 (en) 2004-09-21 2011-02-08 Pavad Medical, Inc. Airway implant sensors and methods of making and using the same
US7882834B2 (en) 2004-08-06 2011-02-08 Fisher & Paykel Healthcare Limited Autotitrating method and apparatus
US8381722B2 (en) 1993-11-05 2013-02-26 Resmed Limited Distinguishing between closed and open airway apneas and treating patients accordingly
US8578937B2 (en) 2004-09-21 2013-11-12 Medtronic Xomed, Inc. Smart mandibular repositioning system
US8997739B2 (en) 1996-10-16 2015-04-07 Resmed Limited Vent valve apparatus
US9526855B2 (en) 1997-11-07 2016-12-27 Resmed Limited Administration of CPAP treatment pressure in presence of apnea
US9649458B2 (en) 2008-09-30 2017-05-16 Covidien Lp Breathing assistance system with multiple pressure sensors
US9974911B2 (en) 1996-09-23 2018-05-22 Resmed Limited Method and apparatus for providing ventilatory assistance
CN108619598A (en) * 2017-03-17 2018-10-09 深圳市大雅医疗技术有限公司 A kind for the treatment of pressure of lung ventilator is from titration system and method
US11077267B2 (en) 2010-12-21 2021-08-03 Fisher & Paykel Healthcare Limited Pressure adjustment method for CPAP machine

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU238077A1 (en) * Е. К. Горбунова, М. Б. Тартаковский, М. С. Ротштейн, DEVICE FOR REGISTRATION OF NOISE OF RESPIRATION
US4347468A (en) * 1980-04-28 1982-08-31 Lake Center Industries Electronic variable speed automotive blower control system
WO1982003548A1 (en) * 1981-04-24 1982-10-28 Sullivan Colin Edward Device for treating snoring sickness
US4430995A (en) * 1981-05-29 1984-02-14 Hilton Joseph R Power assisted air-purifying respirators
AU3389284A (en) * 1983-10-11 1985-04-18 Anthony Russell Dowling Compact self - contained anti-snoring device
EP0171321A1 (en) * 1984-07-27 1986-02-12 Jean Claude Mequignon Device for interrupting the snoring of a sleeping person
WO1986005965A1 (en) * 1985-04-10 1986-10-23 Emergent Technology Corporation Multi-channel ventilation monitor and method
US4630614A (en) * 1984-04-08 1986-12-23 Dan Atlas Apnea monitoring apparatus
US4637386A (en) * 1984-06-14 1987-01-20 Dragerwerk Ag Ventilation system having true valve control for controlling ventilation pressures
WO1987002577A1 (en) * 1985-10-25 1987-05-07 Paolsgaord Goete A device for preventing of snoring

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU238077A1 (en) * Е. К. Горбунова, М. Б. Тартаковский, М. С. Ротштейн, DEVICE FOR REGISTRATION OF NOISE OF RESPIRATION
US4347468A (en) * 1980-04-28 1982-08-31 Lake Center Industries Electronic variable speed automotive blower control system
WO1982003548A1 (en) * 1981-04-24 1982-10-28 Sullivan Colin Edward Device for treating snoring sickness
US4430995A (en) * 1981-05-29 1984-02-14 Hilton Joseph R Power assisted air-purifying respirators
AU3389284A (en) * 1983-10-11 1985-04-18 Anthony Russell Dowling Compact self - contained anti-snoring device
US4630614A (en) * 1984-04-08 1986-12-23 Dan Atlas Apnea monitoring apparatus
US4637386A (en) * 1984-06-14 1987-01-20 Dragerwerk Ag Ventilation system having true valve control for controlling ventilation pressures
EP0171321A1 (en) * 1984-07-27 1986-02-12 Jean Claude Mequignon Device for interrupting the snoring of a sleeping person
WO1986005965A1 (en) * 1985-04-10 1986-10-23 Emergent Technology Corporation Multi-channel ventilation monitor and method
WO1987002577A1 (en) * 1985-10-25 1987-05-07 Paolsgaord Goete A device for preventing of snoring

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DERWENT ABSTRACT ACCESSION NO. 848846/31-16, Class 30a; & SU,A, 238077 (GORBUNOVA), 16 July 1969 (16.07.69). *

Cited By (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6705315B2 (en) 1987-06-26 2004-03-16 Resmed Limited Device for monitoring breathing during sleep and ramped control of CPAP treatment
US5522382A (en) * 1987-06-26 1996-06-04 Rescare Limited Device and method for treating obstructed breathing having a delay/ramp feature
EP0419551A1 (en) * 1988-05-10 1991-04-03 Anatole J Sipin Gas delivery means.
EP0419551A4 (en) * 1988-05-10 1991-08-28 Anatole J. Sipin Gas delivery means
EP0371424A1 (en) * 1988-11-30 1990-06-06 MADAUS SCHWARZER MEDIZINTECHNIK GmbH & Co. KG Monitoring device for the diagnosis of apnea
EP0472664A4 (en) * 1989-05-19 1993-09-15 Puritan-Bennett Corporation Inspiratory airway pressure system
EP0875258A3 (en) * 1989-05-19 1999-02-03 Puritan Bennett Corporation Inspiratory airway pressure system
WO1990014121A1 (en) 1989-05-19 1990-11-29 Puritan-Bennett Corporation Inspiratory airway pressure system
EP0472664A1 (en) * 1989-05-19 1992-03-04 Puritan-Bennett Corporation Inspiratory airway pressure system
US5549106A (en) * 1989-05-19 1996-08-27 Puritan-Bennett Corporation Inspiratory airway pressure system using constant pressure and measuring flow signals to determine airway patency
EP0875258A2 (en) * 1989-05-19 1998-11-04 Puritan Bennett Corporation Inspiratory airway pressure system
WO1991000075A1 (en) * 1989-06-27 1991-01-10 Wennerholm Bjoern Device for temporary artificial respiration assistance for persons having snore problems
US5301689A (en) * 1989-06-27 1994-04-12 Breas Medical Ab Device for temporary artificial respiration assistance for persons having snore problems
EP0968734A3 (en) * 1990-12-21 2000-01-26 Puritan-Bennett Corporation Inspiratory airway pressure system
EP0968734A2 (en) * 1990-12-21 2000-01-05 Puritan-Bennett Corporation Inspiratory airway pressure system
EP0563044A1 (en) * 1990-12-21 1993-10-06 Puritan-Bennett Corporation Inspiratory airway pressure system
EP0563044A4 (en) * 1990-12-21 1994-10-19 Puritan Bennett Corp Inspiratory airway pressure system
US5443061A (en) * 1991-03-21 1995-08-22 Taema Apparatus for providing a breathing gas with an overpressure and process of controlling such apparatus installation
EP0505232A1 (en) * 1991-03-21 1992-09-23 Taema Apparatus providing respiratory gas overpressure, and a control process therefor
FR2674133A1 (en) * 1991-03-21 1992-09-25 Taema SYSTEM FOR PROVIDING BREATHING GAS PRESSURE AND METHOD FOR CONTROLLING SUCH A SYSTEM.
US5458137A (en) * 1991-06-14 1995-10-17 Respironics, Inc. Method and apparatus for controlling sleep disorder breathing
WO1992022244A1 (en) * 1991-06-14 1992-12-23 Respironics, Inc. Method and apparatus for controlling sleep disorder breathing
US6085747A (en) * 1991-06-14 2000-07-11 Respironics, Inc. Method and apparatus for controlling sleep disorder breathing
US5203343A (en) * 1991-06-14 1993-04-20 Board Of Regents, The University Of Texas System Method and apparatus for controlling sleep disorder breathing
EP0612257A4 (en) * 1991-11-14 1994-12-07 Univ Technologies Int Auto cpap system.
EP0612257A1 (en) * 1991-11-14 1994-08-31 University Technologies International Inc. Auto cpap system
EP0639088A1 (en) * 1992-05-07 1995-02-22 New York University Apnea treatment using adjustable positive airway pressure
US5490502A (en) * 1992-05-07 1996-02-13 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
EP0639088B1 (en) * 1992-05-07 2002-07-31 New York University Apparatus for apnea treatment by using adjustable positive airway pressure
US7901361B2 (en) 1992-05-07 2011-03-08 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
FR2692152A1 (en) * 1992-06-15 1993-12-17 Pierre Medical Sa Breathing aid apparatus, in particular for treating sleep apnea.
WO1993025260A1 (en) * 1992-06-15 1993-12-23 Pierre Medical S.A. Breathing aid apparatus particularly for treating sleep apnoea
FR2698274A1 (en) * 1992-11-20 1994-05-27 Sefam Artificial respiration appts. with compression pump - includes pressure sensor and control unit for sensing and preventing any possible blockage of patient's airway
EP0699084A4 (en) * 1992-12-09 1996-06-12 Puritan Bennett Corp Compliance meter for respiratory therapy
EP0699084A1 (en) * 1992-12-09 1996-03-06 Puritan Bennett Corporation Compliance meter for respiratory therapy
US8381722B2 (en) 1993-11-05 2013-02-26 Resmed Limited Distinguishing between closed and open airway apneas and treating patients accordingly
EP0656216A2 (en) * 1993-12-03 1995-06-07 Resmed Limited Estimation of flow and detection of breathing in CPAP treatment
US5740795A (en) * 1993-12-03 1998-04-21 Resmed Limited, An Australian Company Estimation of flow and detection of breathing in CPAP treatment
EP0656216A3 (en) * 1993-12-03 1995-07-05 Rescare Ltd
US5921238A (en) * 1994-09-12 1999-07-13 Nellcor Puritan Bennett France Developpement Pressure-controlled breathing aid
EP0722747A2 (en) * 1994-12-15 1996-07-24 Devilbiss Health Care, Inc. CPAP apparatus
EP0722747A3 (en) * 1994-12-15 1996-10-30 Devilbiss Health Care Inc CPAP apparatus
US5947115A (en) * 1995-01-26 1999-09-07 Respironics, Inc. Gas flow pressure filter
US5537997A (en) * 1995-01-26 1996-07-23 Respironics, Inc. Sleep apnea treatment apparatus and passive humidifier for use therewith
US5540219A (en) * 1995-01-26 1996-07-30 Respironics, Inc. Sleep apnea treatment apparatus
US5655522A (en) * 1995-01-26 1997-08-12 Respironics, Inc. Sleep apnea treatment apparatus and passive humidifier for use therewith
EP0777507A1 (en) * 1995-06-07 1997-06-11 Respironics Inc. Sleep apnea treatment apparatus and humidifier
EP0777507A4 (en) * 1995-06-07 1999-08-04 Respironics Inc Sleep apnea treatment apparatus and humidifier
AU707148B2 (en) * 1995-10-31 1999-07-01 Compumedics Limited Apparatus for gas delivery
US6397845B1 (en) 1995-10-31 2002-06-04 Compumedics, Ltd. Apparatus for gas delivery
WO1997016216A1 (en) * 1995-10-31 1997-05-09 Compumedics Sleep Pty. Ltd. Apparatus for gas delivery
US9974911B2 (en) 1996-09-23 2018-05-22 Resmed Limited Method and apparatus for providing ventilatory assistance
US9770571B2 (en) 1996-10-16 2017-09-26 Resmed Limited Vent valve assembly
US8997739B2 (en) 1996-10-16 2015-04-07 Resmed Limited Vent valve apparatus
US9526855B2 (en) 1997-11-07 2016-12-27 Resmed Limited Administration of CPAP treatment pressure in presence of apnea
WO2001032251A1 (en) * 1999-11-02 2001-05-10 Filderman Rene Artificial ventilation apparatus
FR2800284A1 (en) * 1999-11-02 2001-05-04 Rene Filderman SUPPRESSION OF SOUND DISCOMFORT FROM CONTINUOUS PRESSURE DEVICES FOR THE TREATMENT OF SLEEP APNEA
DE10105383A1 (en) * 2001-02-06 2002-08-08 Heptec Gmbh Anti-snoring device, method for reducing snoring and air glasses
DE10105383C2 (en) * 2001-02-06 2003-06-05 Heptec Gmbh Anti-snoring device
US7107992B2 (en) 2002-10-04 2006-09-19 Pavad Medical, Inc. System and method for preventing closure of passageways
WO2004105846A2 (en) 2003-05-21 2004-12-09 Seleon Gmbh Control device for anti-snoring apparatus and an anti-snoring apparatus, for example for copd treatment
DE10322964B4 (en) * 2003-05-21 2006-03-23 Seleon Gmbh Control unit for anti-snoring device and anti-snoring device
DE10322964A1 (en) * 2003-05-21 2004-12-30 Seleon Gmbh Control unit for anti-snoring device and anti-snoring device
DE102004011078B4 (en) * 2004-03-06 2007-11-15 Golden, Eduard, Dr. Respiratory Equipment
EP1737520A4 (en) * 2004-04-15 2009-10-28 Resmed Ltd Snoring treatment apparatus and methods of managing snorers
US9144654B2 (en) 2004-04-15 2015-09-29 Resmed Limited Snoring treatment apparatus and methods of managing snorers
EP1737520A1 (en) * 2004-04-15 2007-01-03 ResMed Limited Snoring treatment apparatus and methods of managing snorers
US11129949B2 (en) 2004-08-06 2021-09-28 Fisher & Paykel Healthcare Limited Autotitrating method and apparatus
US7882834B2 (en) 2004-08-06 2011-02-08 Fisher & Paykel Healthcare Limited Autotitrating method and apparatus
US9149597B2 (en) 2004-08-06 2015-10-06 Fisher & Paykel Healthcare Limited Autotitrating method and apparatus
US8578937B2 (en) 2004-09-21 2013-11-12 Medtronic Xomed, Inc. Smart mandibular repositioning system
US7882842B2 (en) 2004-09-21 2011-02-08 Pavad Medical, Inc. Airway implant sensors and methods of making and using the same
US7836888B2 (en) 2004-09-21 2010-11-23 Pavad Medical, Incorporated Airway implant and methods of making and using
EP1893264A4 (en) * 2005-06-14 2011-11-23 Resmed Ltd Acclimatization therapy for first time cpap and niv users
US11730906B2 (en) 2005-06-14 2023-08-22 Resmed Pty Ltd. Acclimization therapy for first time CPAP and NIV users
WO2006133493A1 (en) 2005-06-14 2006-12-21 Resmed Limited Acclimatization therapy for first time cpap and niv users
US10821242B2 (en) 2005-06-14 2020-11-03 ResMed Pty Ltd Acclimatization therapy for first time CPAP and NIV users
EP1893264A1 (en) * 2005-06-14 2008-03-05 ResMed Limited Acclimatization therapy for first time cpap and niv users
US9682207B2 (en) 2005-06-14 2017-06-20 Resmed Limited Acclimatization therapy for first time CPAP and NIV users
US10595814B2 (en) 2006-01-06 2020-03-24 ResMed Pty Ltd Computer controlled CPAP system with snore detection
WO2007076582A1 (en) * 2006-01-06 2007-07-12 Resmed Ltd Computer controlled cpap system with snore detection
AU2007203731B2 (en) * 2006-01-06 2013-04-04 ResMed Pty Ltd Computer controlled CPAP system with snore detection
US8365729B2 (en) 2006-01-06 2013-02-05 Resmed Limited Computer controlled CPAP system with snore detection
WO2009103111A1 (en) * 2008-02-19 2009-08-27 Charles Rupert Russell-Smith Patient's breathing detection and monitoring
US9649458B2 (en) 2008-09-30 2017-05-16 Covidien Lp Breathing assistance system with multiple pressure sensors
US11077267B2 (en) 2010-12-21 2021-08-03 Fisher & Paykel Healthcare Limited Pressure adjustment method for CPAP machine
US11744968B2 (en) 2010-12-21 2023-09-05 Fisher & Paykel Healthcare Limited Pressure adjustment method for CPAP machine
CN108619598A (en) * 2017-03-17 2018-10-09 深圳市大雅医疗技术有限公司 A kind for the treatment of pressure of lung ventilator is from titration system and method

Similar Documents

Publication Publication Date Title
US5245995A (en) Device and method for monitoring breathing during sleep, control of CPAP treatment, and preventing of apnea
US6705315B2 (en) Device for monitoring breathing during sleep and ramped control of CPAP treatment
WO1988010108A1 (en) Device for monitoring breathing during sleep and control of cpap treatment
US7913691B2 (en) Session-by-session adjustments of a device for treating sleep disordered breathing
US5901704A (en) Sleep apnea treatment apparatus with minimum leakage assurance circuit
US7013892B2 (en) Sleep apnea treatment apparatus
Prechtl et al. Respiratory muscle EMG in newborns: a non-intrusive method
US20100095959A1 (en) Device for ramped control of cpap treatment
WO1996028093A1 (en) Apparatus and process for reducing the frequency and duration of apneic events
US6155985A (en) Process for determining the image of the nasal and/or buccal respiratory flow of a user
AU2012216551B2 (en) Session-By-Session Adjustment of a Device for Treating Sleep Disordered Breathing

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1988905602

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1988905602

Country of ref document: EP